Staphylococcus aureus (MRSA) Reduction
- Authors
-
Travis R. Farley, Study Director
- Facility
-
Microbac Laboratories, Inc.
- Download
- Full Report
Objective
To evaluate the efficacy of the NV900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).
Methodology
The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the NV900.
Summary of Results
The NV900 reduced 99.99% of Staphylococcus aureus bacteria over the course of four hours.
SUBSCRIBE TO OUR NEWSLETTER
Get news and updates about Novaerus and indoor air quality,
Connect
Partners
